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Sickle cell disease is one of the common hemoglobinopathies in the world. It can aﬀect any part of the body and one of the most
common and an early organ to be aﬀected in SCA is the spleen. It is commonly enlarged during the ﬁrst decade of life but then
undergoes progressive atrophy leading to autosplenectomy. This however is not the case always and sometimes splenomegaly
persist necessitating splenectomy for a variety of reasons including acute splenic sequestration crisis, hypersplenism, massive
splenic infarction and splenic abscess. Splenic complications of SCA are known to be associated with an increased morbidity
and in some it may lead to mortality. To obviate this, splenectomy becomes an essential part of their management. This review is
based on our experience in the management of 173 children with various splenic complications of SCA necessitating splenectomy.
1.Introduction
In 1904, Herrick (1861–1954) was the ﬁrst to describe sickle
cellswhenhisinternErnestEdwardIrons(1877–1959)found
“peculiar elongated and sickle-shaped” red blood cells [1].
This was from a peripheral blood smear of Walter Clement
Noel, a ﬁrst-year dental student from Grenada who was
admitted to the Chicago Presbyterian Hospital suﬀering
from anemia. In 1922, Mason named it “sickle-cell anemia”
[2]. In 1949, Pauling and his colleagues were the ﬁrst to
demonstrate that sickle-cell anemia (SCA) occurs as a result
of an abnormality in the hemoglobin molecule [3]. It is
now well established that SCA results from a single change
of one amino acid, valine instead of glutamic acid at the
sixth position among the 146 amino acids of the hemoglobin
beta chain [4, 5]. This change leads to polymerization of the
hemoglobin whenthe oxygensaturationis lowered, resulting
in deformity of the red blood cells and microvascular occlu-
sion. This as well as its subsequent eﬀects including cellular
dehydration, inﬂammatory response, and reperfusion injury
which are important pathophysiological mechanisms leads
to the diﬀerent manifestations of SCA. In Saudi Arabia,
SCA is common and one of the most aﬀected regions is
the Eastern Province where the frequency of sickle cell trait
can reach as high as 25% in some areas [6, 7].
S C Ai sk n o w nt oa ﬀect any part of the body and
poses diagnostic and therapeutic dilemmas to the treating
physicians. The spleen is one of the most common and early
organs to be aﬀected in SCA. It is commonly enlarged during
theﬁrstdecadeoflifebutthenundergoesprogressiveatrophy
as a result of repeated attacks of vasoocclusion and infarction
leading to autosplenectomy (Figure 1) .T h i s ,h o w e v e r ,i sn o t
the case always and sometimes splenomegaly persists into
an older age group or even into adulthood necessitating
splenectomy for a variety of reasons including acute splenic
sequestration crisis, hypersplenism, massive splenic infarc-
tion and splenic abscess [8–14]. Splenic complications of
SCA are associated with an increased morbidity and in some
it may lead to mortality. To obviate this, splenectomy is an
essential part of their management. Obviously, splenectomy
does not cure SCA, but it is valuable, and in certain
patients may be an essential part of their management. These
complications will be outlined in this paper and the role of
surgery in relation to each will be discussed also.2 ISRN Hematology
Figure 1: Abdominal CT scan showing a small atrophied and
calciﬁed spleen (autosplenectomy).
Figure 2:Clinicalphotographshowinganenlargedspleeninachild
with sickle cell anemia.
Thispaperisbasedonourexperienceinthemanagement
of 173 children with various splenic complications of SCA:
(1) Acute splenic sequestration crisis: 144 children,
(2) Hypersplenism: 18 children,
(3) Splenic abscess: 7 children,
(4) Massive splenic infarction: 3 children,
(5) Splenomegaly with nonfunctioning spleen: 1 child.
2. SplenicSequestration Crisis
Acute splenic sequestration crisis (ASSC) results from the
rapid sequestration of red blood cells in the spleen. It is
a serious complication of SCA and considered the second
Figure 3: Intraoperative photograph showing splenic abscess in a
child with sickle cell anemia.
R
Figure 4: Abdominal CT scan showing a large splenic abscess. Note
the sequestrum of splenic tissue in the abscess cavity.
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Figure 5: Abdominal CT scan showing a large splenic abscess
occupying the whole spleen in a child with sickle cell anemia.ISRN Hematology 3
Figure 6: Clinical intraoperative photograph showing an enlarged
spleen with multiple small infarcts.
Figure 7: Clinical intraoperative photograph showing massive
splenic infarction in a child with sickle cell anemia. Note the
omental adhesions adherent to site of infarction.
leading cause of death after infection in the ﬁrst decade
of life [15–17]. ASSCs are usually seen in infants and
young children commonly between 5 months and 2 years
of age. Of interest was the ﬁnding that our patients with
ASSC are older (mean 7.6 year) when compared to reports
from other parts of the world [8, 9, 15–17]. The exact
reason for this is not known (Figure 2). One contributing
factor is persistence of splenomegaly in our patients into
an older age group [8, 9]. This is partly attributed to
persistently high hemoglobin F level in our patients (mean
hemoglobin F 20.5%). ASSC is characterized by sudden
onset of anemia, splenomegaly, evidence of active bone
marrow,andthespleensizeregressesafterbloodtransfusion.
This diﬀerentiates ASSC from hypersplenism where the
spleen size is chronically enlarged and does not regress after
















Figure 8: Abdominal CT scan showing massive splenic infarction
in a child with sickle cell anemia.
attacks depending on the severity of the attack. In minor
attacks, there is a moderate increase in the size of the spleen
with a sudden drop of hemoglobin of 2-3g/dl. In major
attacks, there is a signiﬁcant sudden increase is spleen size,
a greater drop of hemoglobin sometimes decreasing to reach
as low as 2-3g/dl and hypovolemia [8, 9].
The cause of ASSC is not known but an association with
upper respiratory tract infection suggesting a precipitating
viral cause was proposed. Mallouh and Qudah reported
3 patients with major ASSC associated with aplastic crisis
caused by human paravirus B19 [18]. The indication for
splenectomy in major attacks is well established and like
others, we advocate splenectomy if the child develops one
major attack [8, 9, 15–17]. Some of our patients had more
than one major attack as a result of parent’s initial refusal
for splenectomy. Major ASSC is a serious complication that
is associated with a high mortality [15, 19]. To obviate this,
the parents should be taught how to palpate the spleen and
report to the hospital if they recognize sudden enlargement.
Fortunately, none of our patients died from major ASSC, but
one of them was brought to the hospital comatosed with
subsequent neurological deﬁcit as a result of hypovolemia
and hypoxic encephalopathy. This however does not exclude
the possibility of a hidden mortality as a result of deaths
prior to arrival to hospital in these patients. The role of
splenectomy in minor attacks is still controversial. Some
advocate chronic blood transfusion as a therapy to prevent
recurrent attacks [14]. This is eﬀective on the short term but
it is not without risks including allosensitization, hepatitis
and other bloodborn, infections. Add to this, the fact that a
signiﬁcant number of patients on chronic blood transfusion
therapy developed ASSC when attempts were made to stop
blood transfusion or shortly after completing the program
[20]. The fact that blood is not readily available in our
setting and poor compliance of parents, makes chronic
blood transfusion unsuitable form of therapy. We like others
advocatesplenectomyifthechilddevelopstwominorattacks
[8, 12]. This is to obviate a recurrence risk of 40%–50%4 ISRN Hematology
and a mortality rate as high as 20% [15, 19]. ASSC was
the commonest indication for splenectomy in our patients.
144 (83%) children had splenectomy for acute splenic
sequestration crisis. 36 of them had major attacks with a
drop in their hemoglobin as low as 1.8–4.1g/dl, and 108 had
minor recurrent attacks [8, 9]. Their mean age was 7.6 years
(range 1.8–13 years) and their mean hemoglobin F level was
20.5% (9.2–36.9%).
3. Hypersplenism
Hypersplenism is arbitrarily deﬁned as splenomegaly
with anemia (when the transfusion requirements exceeds
250ml/kg of packed red blood cells per year), thrombocy-
topenia (when the platelets level is less than 100,000/mm3),
neutropenia (when the white blood cell count is less than
4,000/mm3) either singly or in combination.
Hypersplenism was the second indication for splenec-
tomy in our patients. Only 18 of our patients had hyper-
splenism and 7 of them had Sickle-B-Thalassemia. The
reason for this low incidence of hypersplenism in our series
is not known. In the past minor ASSC was confused with
hypersplenism,butwhenweappliedstrictdeﬁnitioncriteria,
we found a low incidence of hypersplenism in our series. The
fact that 7 of our patients with hypersplenism had Sickle-
B-Thalassemia conﬁrms the observation that patients with
Sickle-B-Thalassemia tend to behave more like thalassemia
[21]. To obviate the risk of overwhelming postsplenec-
tomy infection (OPSI), a variety of treatment modalities
other than total splenectomy have been proposed to treat
patients with hypersplenism. These include chronic blood
transfusions,partialsplenectomy,percutaneousintraluminal
occlusion of the splenic artery, and embolic therapy [22–
25]. Chronic blood transfusion has its own complications
including alloimmunization, which occurs in up to 20% of
multiplytransfusedpatientsandtransmissionofbloodborne
infections [26]. The poor compliance of parents and the fact
that blood is not readily available makes this form of therapy
unsuitable for our patients. Partial splenic embolization
although has been shown to be safe and reliable method
of treatment of hypersplenism, it has its own complications
which makes it unsuitable form of treatment for patients
with SCA [27–29]. We found splenectomy in SCA patients
withhypersplenism to be beneﬁcial in decreasing their trans-
fusion requirements and eliminating the discomfort from
mechanical pressure of the enlarged spleen. We compared
the preoperative blood parameters (the pretransfusion levels
nearest to the date of splenectomy) to those postsplenectomy
(means of multiple estimates taken postoperatively and
during followups in the clinic) and found a signiﬁcant
increase in the hemoglobin level, platelets, white blood cells
and a signiﬁcant decrease in the levels of reticulocytes [8].
4. SplenicAbscess
Splenic abscess is rare accounting for 0.14% to 0.7% of
necropsy specimens [30]. Recently, there is a change in
the spectrum of splenic abscess with emergence of unusual
causative organisms as well as more cases being described
in immunocompromized patients [31–35]. Several factors
have been described to predispose to splenic abscess, but
in a large series of 173 patients with splenic abscess, sepsis
was the commonest predisposing factor in 73.4% of the
cases, with infective endocarditis being the commonest [35].
Splenic abscess is very rare in patients with SCA as these
patients tend to have early autosplenectomy. Persistence
of splenomegaly in our patients, however, predisposes
them to the development of splenic infarction. The early
development of functional asplenia makes them liable to
systemic infections and in the presence of splenic infarction
predisposes them to the development of splenic abscess
[10, 14]. Seven of our patients had splenectomy for splenic
abscesswhichremainsadiagnosticchallenge(Figure 3).This
is specially so in children with SCA who frequently present
with fever due to other infective causes and abdominal pain
which is commonly attributed to vasoocclusive crisis. This
as well as the rarity of splenic abscess leads to delay in
diagnosis. Physicians caring for these patients should be
aware of such a complication and the possibility of splenic
abscess should be considered in children with SCA who
present with fever and abdominal pain specially if found
to have a tender enlarged spleen. We also advocate the
liberal use of abdominal ultrasound in these patients as it is
simple, noninvasive and easily repeatable investigation and
if in doubt, the diagnosis can be conﬁrmed by abdominal
CT scan (Figure 4). Although abdominal ultrasound was
diagnostic, we found CT scan more valuable as it allows
more accurate anatomical localization of site and size of
the abscess (Figure 5). A variety of organisms can cause
splenic abscess including staphylococci, Streptococci, and
gram negative bacilli but of interest was the ﬁnding of
Salmonella as a causative organism in 5 of our patients.
Salmonella is known to cause a variety of infections in
patients with SCA including septic arthritis, osteomyelitis,
and septicemia [36, 37]. This is of paramount importance
when considering antibiotic coverage as this should include
antibiotics against Salmonella till the culture and sensitivity
results become available. In the past, total splenectomy was
the treatment of choice for splenic abscess. To obviate OPSI,
splenicpreservationwasadvocatedeveninthosewithsplenic
abscess. A variety of procedures have been proposed includ-
ing partial splenectomy, CT-guided percutaneous catheter
drainage, or even noninterventional treatment of splenic
abscess with antibiotics [38–41]. We advocate splenectomy
and antibiotic coverage for children with SCA and splenic
abscess as there is no point in preserving a nonfunctioning
spleenwhichispresentinthemajorityofthem.Percutaneous
abscess drainage and in the presence of personal experienced
in this technique can be used as a temporary measure in
children who are sick to undergo laparotomy [10, 14].
5. MassiveSplenic Infarction
Splenic infarctions secondary to vasoocclusion are common
in patients with SCA (Figure 6). They however occur early
and usually are small, unnoticeable, and repetitive leadingISRN Hematology 5
to progressive atrophy and ultimately to autosplenectomy.
Massive splenic infarction which is arbitrarily deﬁned as
infarction involving more than 50% of the spleen size is
almost unknown among adults with SCA, but there are
reports of massive splenic infarcts in patients with sickle cell
trait, and hemoglobin SE and SC disease, seen particularly
in association with stress or following air travel especially in
an unpressurized aircrafts [42–46]. In sickle cell trait, large
splenic infarcts in the normal sized spleen were reported
following exposure to hypoxia during high altitude ﬂights
in an unpressurized air planes or during mountain climbing
[47]. Sleep apnea with attendant hypoxia was also implicated
as a possible cause in some cases of splenic infarcts in sickle
cell trait without apparent precipitating factor [45]. Massive
splenic infarcts had also been reported in other sickle cell
variants where splenomegaly is common, mainly in HbSC
disease, Sβ+ Thalassemia and in HbSE disease [48]. Massive
splenic infarction is a rare and unique complication of SCA
[13]. Three of our patients aged 8, 10, and 14 years had
massive splenic infarction (Figure 7). All had splenomegaly
and there was no obvious precipitating factor for the infarc-
tion but stress in the form of generalized vasoocclusive crisis
may have played a role. All patients had left upper quadrant
abdominal pain and clinically had a tender enlarged spleen.
This should hint to the possibility of splenic infarction,
and with the availability of ultrasound examination, it is
now possible to diagnose splenic infarction early and to
follow the progress of this complication. Computerized
tomography (CT) of the abdomen on the other hand is
more valuable in demonstrating the extent of the infarct
(Figure 8).
The clinical presentation and radiological features of
massive splenic infarction can resemble those with splenic
abscess, and it is important to diﬀerentiate between the two
as massive splenic infarction can be treated conservatively
ultimately leading to autosplenectomy [46]. The manage-
ment of such a complication is challenging both to the
physicians and the surgeons, and a team work approach is
most fruitful. The majority of the patients are febrile, and
in the presence of massive splenic infarct, the possibility of
splenic abscess although rare must be excluded. The two in
doubtful cases can also be diﬀerentiated by percutaneous
aspiration under ultrasound guidance. These patients should
be covered with antibiotics after obtaining the necessary
cultures, and a conservative approach is now recommended
inthemanagementofthesecases[13,48].Surgeryisreserved





In the past and because of a perioperative mortality as
high as 10% and a postoperative morbidity up to 50%,
surgery was not advocated in patients with SCA except
in symptomatic patients [49–51]. This however is not the
case nowadays as with better understanding of SCA, and
i m p r o v e dp e r i o p e r a t i v ec a r e ,s u r g e r yi ss a f e r .T h i si sa l s o
the case for children undergoing splenectomy. Splenectomy
in these patients should be avoided as much as possible as
thesepatientsareknowntobemoresusceptibletoinfections.
In the past, we used to see postsplenectomy complications
including acute chest syndrome which can be severe and
life threatening. We adopted a perioperative management
plan for all these patients and since then, the number of
postoperative complications has decreased markedly. Our
perioperative management includes the following.
(1) Clinical evaluation.
(2) Preoperative hydration with intravenous ﬂuids at a
rate of 1.5 their maintenance. This starts the night
before surgery and continues postoperatively till they
have adequate oral intake.
(3) All patients are immunized with pneumococcal,
meningococcal, H. inﬂuenza vaccines at least 10–14
days preoperatively. This is given postoperatively for
those who require an emergency operation.
(4) Preoperative blood transfusion to increase their
hemoglobin to 10-11g/dl with packed red blood cells
and using this formula (weight in Kg×(hemoglobin
desired − actual hemoglobin) ×3).
(5) At the time of surgery, avoid hypoxia, acidosis,
hypothermia, and hypercarbia.
(6) Adequate analgesia postoperatively.
(7) Early mobilization and chest physiotherapy using
incentive spirometry.
In 1991, Delaitre and Maignien reported the ﬁrst laparo-
scopic splenectomy in an adult [52]. Since then, laparo-
scopic splenectomy has become the procedure of choice to
treat hematological disorders requiring splenectomy both
in children and adults [53–57]. We performed laparoscopic
splenectomy for 41 children with SCA; seven of them
had laparoscopic splenectomy and cholecystectomy. Laparo-
scopicsplenectomyisfeasibleandsafeforchildrenwithSCA.
Currently, it requires more operative time than the open
splenectomy because of the large size of the spleen and sever
adhesions but when compared with open splenectomy it is
superior in term of cosmetic appearance, shorter hospital
stay, early postoperative recovery, and less postoperative
complications [58]. Laparoscopic splenectomy should now
bethetreatmentofchoiceforallchildrenwithSCArequiring
splenectomy.
7. Overwhelming Postsplenectomy Sepsis
There is growing concern about overwhelming postsplenec-
tomy infection, which is certainly a hazard [59, 60]. The true
incidence of OPSI however, remains to be established, but it
is greatest in children in whom splenectomy was performed
in the ﬁrst few years. OPSI is seen commonly within the ﬁrst
two years following splenectomy. Streptococcus pneumonia
is the commonest organism causing OPSI, followed by
Hemophilus inﬂuenza and Nisseria meningitides. To obviate6 ISRN Hematology
this, we immunize our patients with pneumococcal as well
as H. inﬂuenza and meningococcal vaccines. We also cover
themwithpenicillinprophylaxiseitherorallyorintramuscu-
larlyfor2-3yearsfollowingsplenectomy.Theeﬀectivenessof
such prophylaxis in an era of increasing microbial resistance
toantibioticsneedshowevertobeevaluated.Wealsoeducate
the parents that they should seek medical help at the earliest
sign of an infection. A point of concern in Saudi children
with SCA is their increased susceptibility to Salmonella
infections. This should be evaluated further in term of long-
termantibioticprophylaxisaswellasthefeasibilityofﬁnding
a vaccine against Salmonella.
References
[ 1 ] J .B .H e r r i c k ,“ P e c u l i a re l o n g a t e da n ds i c k l e - s h a p e dr e db l o o d
corpuscles in a case of severe anemia,” Archives of Internal
Medicine, vol. 6, p. 517, 1910.
[ 2 ]V .R .M a s o n ,“ S i c k l ec e l la n e m i a , ”Journal of the American
Medical Association, vol. 79, pp. 1318–1320, 1922.
[3] L. Pauling, H. A. Itano, S. J. Singer, and I. C. Wells, “Sickle cell
anemia, a molecular disease,” Science, vol. 110, no. 2865, pp.
543–548, 1949.
[4] V. M. Ingram, “A speciﬁc chemical diﬀerence between
the globins of normal human and sickle-cell anæmia
hæmoglobin,” Nature, vol. 178, no. 4537, pp. 792–794, 1956.
[5] V. M. Ingram, “Gene mutations in human hæmoglobin:
the chemical diﬀerence between normal and sickle cell
hæmoglobin,” Nature, vol. 180, no. 4581, pp. 326–328, 1957.
[6] R. P. Perrine, M. E. Pembrey, P. John, S. Perrine, and F. Shouf,
“Natural history of sickle cell disease in the Eastern Province





[8] A. H. Al-Salem, “Indications and complications of splenec-
tomy for children with sickle cell disease,” Journal of Pediatric
Surgery, vol. 41, no. 11, pp. 1909–1915, 2006.
[9] A. H. Al Salem, S. Qaisaruddin, Z. Nasserullah, I. Al Dabbous,
H. Abu Srair, and A. Al Jam’a, “Splenectomy and acute splenic
sequestration crises in sickle cell disease,” Pediatric Surgery
International, vol. 11, no. 1, pp. 26–28, 1996.
[10] A. H. Al-Salem, K. Kadappa Mallapa, S. Qaisaruddin, A. Al-
Jam’a,andA.Elbashir,“Splenicabscessinchildrenwithsickle-
cell disease,” Pediatric Surgery International,v o l .9 ,n o .7 ,p p .
489–491, 1994.
[ 1 1 ]R .N .H a r i c h a r a n ,J .M .R o b e r t s ,T .L .M o r g a ne ta l . ,
“Splenectomyreducespackedredcelltransfusionrequirement
inchildrenwithsicklecelldisease,”JournalofPediatricSurgery,
vol. 43, no. 6, pp. 1052–1056, 2008.
[12] A. M. Emond, P. Morais, and S. Venugopal, “Role of splenec-
tomy in homozygous sickle cell disease in childhood,” Lancet,
vol. 1, no. 8368, pp. 88–91, 1984.
[ 1 3 ] A .H .A lJ a m a ,A .H .A lS a l e m ,a n dI .A .A lD a b b o u s ,“ M a s s i v e
splenic infarction in Saudi patients with sickle cell anemia: a
unique manifestation,” American Journal of Hematology, vol.
69, no. 3, pp. 205–209, 2002.
[14] A. H. Al-Salem, S. Qaisaruddin, A. Al Jam’a, J. Al-Kalaf, and
A. M. El-Bashier, “Splenic abscess and sickle cell disease,”
American Journal of Hematology, vol. 58, no. 2, pp. 100–104,
1998.
[15] A. M. Emond, R. Collis, and D. Darvill, “Acute splenic seques-
tration in homozygous sickle cell disease: natural history and
management,” Journal of Pediatrics, vol. 107, no. 2, pp. 201–
206, 1985.
[16] R. W. Powell, G. L. Levine, Y.-M. Yang, and V. N. Mankad,
“Acute splenic sequestration crisis in sickle cell disease: early
detection and treatment,” Journal of Pediatric Surgery, vol. 27,
no. 2, pp. 215–219, 1992.
[17] J. M. Topley, D. W. Rogers, M. C. G. Stevens, and G. R.
Serjeant, “Acute splenic sequestration and hypersplenism in
the ﬁrst ﬁve years in homozygous sickle cell disease,” Archives
of Disease in Childhood, vol. 56, no. 10, pp. 765–769, 1981.
[18] A. A. Mallouh and A. Qudah, “Acute splenic sequestration
together with aplastic crisis caused by human parvovirus B19
in patients with sickle cell disease,” Journal of Pediatrics, vol.
122, no. 4, pp. 593–595, 1993.
[19] M. L. Mills, “Life-threatening complications of sickle cell dis-
ease in children,” Journal of the American Medical Association,
vol. 254, no. 11, pp. 1487–1491, 1985.
[20] T. R. Kinney, R. E. Ware, W. H. Schultz, and H. C. Filston,
“Long-term management of splenic sequestration in children
with sickle cell disease,” Journal of Pediatrics, vol. 117, pp. 194–
199, 1990.
[21] B. H. Al-Awamy, G. A. Niazi, and M. I. El-Mouzan, “Relation-
ship of haemoglobin F and alpha thalassaemia to severity of
sickle-cell anaemia in the Eastern Province of Saudi Arabia,”
Annals of Tropical Paediatrics, vol. 6, no. 4, pp. 261–265, 1986.
[22] K. C. Pringle, D. G. Spigos, and W. S. Tan, “Partial splenic
embolization in the management of thalassemia major,”
Journal of Pediatric Surgery, vol. 17, no. 6, pp. 884–891, 1982.
[23] J. M. Levy, P. Wasserman, and N. Pitha, “Presplenectomy
transcatheter occlusion of the splenic artery,” Archives of
Surgery, vol. 114, no. 2, pp. 198–199, 1979.
[24] C. L. Witte, D. B. Van Wyck, and M. H. Witte, “Ischaemia and
partial resection for control of splenic hyperfunction,” British
Journal of Surgery, vol. 69, no. 9, pp. 531–535, 1982.
[25] A. Alwmark, S. Bengmark, P. Gullstrand et al., “Evaluation of
splenic embolization in patients with portal hypertension and
hypersplenism,”AnnalsofSurgery,vol.196,no.5,pp.518–524,
1982.
[ 2 6 ]S .C .D a v i e s ,A .C .M c W i l l i a m ,P .E .H e w i t te ta l . ,“ R e d
cell alloimmunization in sickle cell disease,” British Journal of
Haematology, vol. 3, pp. 29–44, 1986.
[27] W. R. Castaneda-Zuniga, D. E. Hammerschmidt, R. Sanchez,
andK.Amplatz,“Nonsurgicalsplenectomy,”AmericanJournal
of Roentgenology, vol. 129, no. 5, pp. 805–811, 1977.
[28] D. G. Spigos, O. Jonasson, M. Mozes, and V. Capek, “Partial
splenic embolization in the treatment of hypersplenism,”
American Journal of Roentgenology, vol. 132, no. 5, pp. 777–
782, 1979.
[29] M. H. Wholey, H. A. Chamorro, G. Rao, and W. Chapman,
“Splenic infarction and spontaneous rupture of the spleen
after therapeutic embolization,” CardioVascular and Interven-
tional Radiology, vol. 1, no. 4, pp. 249–253, 1978.
[30] T. R. Gadacz, “Splenic abscess,” World Journal of Surgery, vol.
9, no. 3, pp. 410–415, 1985.
[31] R.M.Hately,J.S.Donaldson,andJ.G.Raﬀsenperger,“Splenic
microabscesses in the immunocompromised patient,” Journal
of Pediatric Surgery, vol. 24, pp. 697–699, 1989.
[32] L. M. Marmon, C. D. Vinocur, R. S. Wimmer, S. H. Konefal,
and W. H. Weintraub, “Fungal splenic abscesses: management
in childhood leukemia,” Pediatric Surgery International, vol. 5,
no. 2, pp. 118–120, 1990.ISRN Hematology 7
[33] L. L. P. J. Ooi, R. Nambiar, A. Rauﬀ,P .O .P .M a c k ,a n dT .L .
Yap, “Splenic abscess,” Australian and New Zealand Journal of
Surgery, vol. 62, no. 10, pp. 780–784, 1992.
[34] M. A. Cheema, A. A. Al-Saigh, and A. B. A. Latif, “Splenic
abscess: presentation, diagnosis and management,” Annals of
Saudi Medicine, vol. 12, no. 6, pp. 552–554, 1992.
[ 3 5 ]M .D .S m i t hJ r . ,M .N i o ,J .E .C a m e l ,J .K .S a t o ,a n dJ .B .
Atkinson, “Management of splenic abscess in immunocom-
promised children,” Journal of Pediatric Surgery,v o l .2 8 ,n o .6 ,
pp. 823–826, 1993.
[36] A. H. Al-Salem, H. A. Ahmed, S. Qaisaruddin, A. Al-Jam, A.
M. Elbashier, and I. Al-Dabbous, “Osteomyelitis and septic
arthritis in sickle cell disease in the eastern province of Saudi
Arabia,” International Orthopaedics, vol. 16, no. 4, pp. 398–
402, 1992.
[37] A. M. Elbashier, A. H. Al- Salem, and A. Aljama, “Salmonella
as a causative organism of various infections in patients with
sickle cell disease,” Annals of Saudi Medicine,v o l .2 3 ,n o .6 ,p p .
358–362, 2003.
[38] W. A. Berkman, S. A. Harris Jr., and M. E. Bernardino,
“Nonsurgical drainage of splenic abscess,” American Journal of
Roentgenology, vol. 141, no. 2, pp. 395–396, 1983.
[39] R. M. Lerner and R. F. Spataro, “Splenic abscess: percutaneous
drainage,” Radiology, vol. 153, pp. 643–645, 1984.
[40] E. T. Fernandes, P. B. Tavares, and C. B. M. Garcette,
“Conservative management of splenic abscesses in children,”
Journal of Pediatric Surgery, vol. 27, no. 12, pp. 1578–1579,
1992.
[41] N. Bhattacharyya, D. S. Ablin, and A. M. Kosloske, “Stapled
partial splenectomy for splenic abscess in a child,” Journal of
Pediatric Surgery, vol. 24, no. 3, pp. 316–317, 1989.
[42] R. L. Green, R. G. Huntsman, and G. R. Serjeant, “The sickle-
cell and altitude,” British Medical Journal, vol. 4, no. 787, pp.
593–595, 1971.
[43] K. Y. Yeung and L. S. Lessin, “Splenic infarction in sickle cell
hemoglobin C disease,” Archives of Internal Medicine, vol. 136,
no. 8, pp. 905–911, 1976.
[44] M. Lipschutz, D. A. McQueen, and F. Rosner, “Spontaneous
rupture of the spleen in homozygous hemoglobin C disease,”
JournaloftheAmericanMedicalAssociation,vol.237,no.8,pp.
792–793, 1977.
[45] I. Bodo, S. P. Dun Hey, M. Blinder, and G. Broze, “Low
altitude splenic infarction in sickle cell trait, is sleep apnea the
solution to the mystery? A case report,” Blood, vol. 90, no. 10,
supplement 1, part 2, p. 23, 1997, abstract no. 2788.
[46] W. A. Coleman and F. W. Furth, “Splenic infarction in a
patient with sickle cell hemoglobin C disease, report of a case
following air travel,” Archives of Internal Medicine, vol. 98, pp.
247–249, 1956.
[47] A. E. Stock, “Splenic infarction associated with high altitude
ﬂying and sickle cell trait,” Annals of Internal Medicine, vol. 44,
pp. 554–556, 1956.
[48] K. Y. Yeung and L. S. Lessin, “Splenic infarction in sickle
cell hemoglobin C disease. Demonstration by selective splenic
arteriogram and scintillation scan,” Archives of Internal
Medicine, vol. 136, no. 8, pp. 905–911, 1976.
[49] K. A. Oduro and J. F. Searle, “Anaesthesia in sickle-cell states: a
plea for simplicity,” British Medical Journal, vol. 4, no. 840, pp.
596–598, 1972.
[50] J. F. Searle, “Anaesthesia in sickle cell states. A review,”
Anaesthesia, vol. 28, no. 1, pp. 48–58, 1973.
[51] O. S. Platt, D. J. Brambilla, W. F. Rosse et al., “Mortality in
sickle cell disease: life expectancy and risk factors for early
death,” New England Journal of Medicine, vol. 330, no. 23, pp.
1639–1644, 1994.
[52] B.DelaitreandB.Maignien,“Splenectomybythelaparoscopic
a p p r o a c h .R e p o r to fac a s e , ”Presse Medicale, vol. 20, no. 44, p.
2263, 1991.
[53] C. Thibault, J. Mamazza, R. Letourneau, and E. Poulin,
“Laparoscopic splenectomy: operative technique and prelimi-
nary report,” Surgical Laparoscopy and Endoscopy, vol. 2, no. 3,
pp. 248–253, 1992.
[54] S. Tulman, G. W. Holcomb III, H. L. Karamanoukian, and
J. Reynhout, “Pediatric laparoscopic splenectomy,” Journal of
Pediatric Surgery, vol. 28, no. 5, pp. 689–692, 1993.
[55] R. Pugliese, F. Sansonna, I. Scandroglio et al., “Laparoscopic
splenectomy: a retrospective review of 75 cases,” International
Surgery, vol. 91, no. 2, pp. 82–86, 2006.
[ 5 6 ]D .C .M o o r e s ,M .A .M c K e e ,H .W a n g ,J .D .F i s c h e r ,J .W .
Smith, and H. G. Andrews, “Pediatric laparoscopic splenec-
tomy,” Journal of Pediatric Surgery, vol. 30, no. 8, pp. 1201–
1205, 1995.
[57] B. H. Nilsen, T. Haugstvedt, P. Odland, and A. Viste, “Laparo-
scopic splenectomy in children: surgical technique,” European
Journal of Surgery, vol. 161, no. 3, pp. 199–201, 1995.
[58] A. Alwabari, L. Parida, and A. H. Al-Salem, “Laparoscopic
splenectomy and/or cholecystectomy for children with sickle
cell disease,” Pediatric Surgery International,v o l .2 5 ,n o .5 ,p p .
417–421, 2009.
[59] H. King and H. B. Schumacher Jr., “Splenic studies. I.
Susceptibility to infection after splenectomy performed in
infancy,” Annals of surgery, vol. 136, no. 2, pp. 239–242, 1952.
[60] D. J. Waghorn, “Overwhelming infection in asplenic patients:
current best practice preventive measures are not being
followed,” Journal of Clinical Pathology, vol. 54, no. 3, pp. 214–
218, 2001.